Fundz

Advaxis, Inc. reported raising $4.75 Million in an initial SEC Form D filing, from an offering of $4.75 Million

PRIVATEFeb 11, 2022

Amount Raised

$4.75 Million

$4.75 Million sold, per SEC Form D (first sale Feb 11, 2022)

Round Type

Seed

Monmouth JunctionBiotechnology

Quick answer

Ayala Pharmaceuticals raised $4.75 Million in a Seed round, dated February 11, 2022. Ayala Pharmaceuticals is based in Monmouth Junction, New Jersey, United States.

How much did Ayala Pharmaceuticals raise?
Ayala Pharmaceuticals raised $4.75 Million in a Seed round on February 11, 2022.
What does Ayala Pharmaceuticals do?
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.
Where is Ayala Pharmaceuticals based and how big is it?
Ayala Pharmaceuticals is based in Monmouth Junction, New Jersey, United States.
Who are the decision-makers at Ayala Pharmaceuticals?
Fundz holds 1 contact at Ayala Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Ayala Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Aviceda Therapeutics raised $75M on March 28, 2022.
  • Aspargo Laboratories raised $1.5M (Seed) on March 28, 2022.
  • Aldebaran Therapeutics, Inc. raised $800K (Seed) on March 28, 2022.
  • Aviceda Therapeutics raised $8.4M on March 28, 2022.
  • Ophirex, Inc. raised $16M on March 28, 2022.
  • Elucida Oncology raised $22M on March 28, 2022.

Who to call at Ayala Pharmaceuticals, and when

A new round usually means Ayala Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ayala Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ayala Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ayala Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ayala Pharmaceuticals

Location

Monmouth Junction, New Jersey, United States

About

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. We are also developing proprietary Lm-based antigen delivery products for patients suffering from more common cancers. Our lead candidates under development are the oral gamma secretase inhibitor, AL102, for desmoid tumors; ADXS-504, a Lm-based therapy for early-stage prostate cancer, and the intravenous gamma secretase inhibitor, AL101, for adenoid cystic carcinoma. AL102 (RINGSIDE) has received Fast Track Designation from the U.S. FDA and is currently in the Phase 3 segment of a pivotal study for patients with desmoid tumors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ayala Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts16 people are listed at Ayala Pharmaceuticals. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ayala Pharmaceuticals's next move

See what Strategic adds

Ayala Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.